ARTNet Working Groups

ARTNet focuses on the mechanistic bases of acquired resistance to cancer therapies and disease recurrence. Its central goal is to balance basic, pre-clinical, and translational research using an iterative team science structure that will enable hypothesis testing on the biological basis of resistance in clinically relevant model systems. ARTNet also aims to provide evidence along the shared tumor-tumor microenvironment (TME) continuum to inform new strategies that can be better translated into future clinical trials. Towards this goal, the ARTNet has initiated a two cross-cutting functional Working Groups with the broad goals to identify and address barriers to progress, and pioneer advances in the field.